173 related articles for article (PubMed ID: 9857272)
1. Comprehensive cardiac rehabilitation improves the control of dyslipidemia in secondary prevention.
Vergès BL; Patois-Vergès B; Cohen M; Casillas JM
J Cardiopulm Rehabil; 1998; 18(6):408-15. PubMed ID: 9857272
[TBL] [Abstract][Full Text] [Related]
2. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
3. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
4. The surveillance of cholesterol management in the cardiac rehabilitation setting.
Wyman R; Vitcenda M; McBride P
J Cardiopulm Rehabil; 2002; 22(4):245-50. PubMed ID: 12202843
[TBL] [Abstract][Full Text] [Related]
5. Emphasis on high-density lipoprotein cholesterol in patients with coronary artery disease.
Mailander L; Lavie CJ; Milani RV; Gaudin D
South Med J; 1993 May; 86(5):508-12. PubMed ID: 8488395
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting improvements in lipid values following cardiac rehabilitation and exercise training.
Lavie CJ; Milani RV
Arch Intern Med; 1993 Apr; 153(8):982-8. PubMed ID: 8481069
[TBL] [Abstract][Full Text] [Related]
7. The impact of complex cardiac rehabilitation on manifestation of risk factors in patients with coronary heart disease.
Kubilius R; Jasiukevičienė L; Grižas V; Kubilienė L; Jakubsevičienė E; Vasiliauskas D
Medicina (Kaunas); 2012; 48(3):166-73. PubMed ID: 22588350
[TBL] [Abstract][Full Text] [Related]
8. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
[TBL] [Abstract][Full Text] [Related]
9. Impact of duration in a cardiac rehabilitation program on coronary risk profile and health-related quality of life outcomes.
Morrin L; Black S; Reid R
J Cardiopulm Rehabil; 2000; 20(2):115-21. PubMed ID: 10763159
[TBL] [Abstract][Full Text] [Related]
10. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
11. Effects of cardiac rehabilitation and exercise training in obese patients with coronary artery disease.
Lavie CJ; Milani RV
Chest; 1996 Jan; 109(1):52-6. PubMed ID: 8549217
[TBL] [Abstract][Full Text] [Related]
12. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
Isles CG; Paterson JR
QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
[TBL] [Abstract][Full Text] [Related]
13. The Benefits of a Comprehensive Cardiac Rehabilitation Program for Patients with Acute Coronary Syndrome: A Follow-Up Study.
Craciun LM; Buleu F; Pah AM; Badalica-Petrescu M; Bodea O; Man DE; Cosor OC; Iurciuc S; Dragan S; Rada M
J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888127
[TBL] [Abstract][Full Text] [Related]
14. [Inpatient rehabilitation improves implementation of therapeutic guidelines for secondary prevention in patients with coronary heart disease].
Baessler A; Fischer M; Hengstenberg C; Holmer S; Hubauer U; Huf V; Mell S; Klein G; Riegger G; Schunkert H
Z Kardiol; 2001 Sep; 90(9):646-54. PubMed ID: 11677801
[TBL] [Abstract][Full Text] [Related]
15. Lipid lowering in the cardiac rehabilitation setting.
Ades PA; Savage PD; Poehlman ET; Brochu M; Fragnoli-Munn K; Carhart RL
J Cardiopulm Rehabil; 1999; 19(4):255-60. PubMed ID: 10453433
[TBL] [Abstract][Full Text] [Related]
16. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
Athyros VG; Papageorgiou AA; Mercouris BR; Athyrou VV; Symeonidis AN; Basayannis EO; Demitriadis DS; Kontopoulos AG
Curr Med Res Opin; 2002; 18(4):220-8. PubMed ID: 12201623
[TBL] [Abstract][Full Text] [Related]
17. Differential improvements in lipid profiles and Framingham recurrent risk score in patients with and without diabetes mellitus undergoing long-term cardiac rehabilitation.
Carroll S; Tsakirides C; Hobkirk J; Moxon JW; Moxon JW; Dudfield M; Ingle L
Arch Phys Med Rehabil; 2011 Sep; 92(9):1382-7. PubMed ID: 21878208
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a planned strategy using cardiac rehabilitation nurses for the management of dyslipidemia in patients with coronary artery disease.
Senaratne MP; Griffiths J; Mooney D; Kasza L; Macdonald K; Hare S
Am Heart J; 2001 Dec; 142(6):975-81. PubMed ID: 11717600
[TBL] [Abstract][Full Text] [Related]
19. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
Allison TG; Squires RW; Johnson BD; Gau GT
Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
[TBL] [Abstract][Full Text] [Related]
20. Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterol.
Rubins HB; Schectman G; Wilt TJ; Iwane MK
Arch Intern Med; 1992 Dec; 152(12):2412-6. PubMed ID: 1456850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
